Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice.

Hansen, Henrik H; Grønlund, Rikke V; Baader-Pagler, Tamara; Haebel, Peter; Tammen, Harald; Larsen, Leif Kongskov; Jelsing, Jacob; Vrang, Niels; Klein, Thomas

Hansen, Henrik H; Grønlund, Rikke V; Baader-Pagler, Tamara; Haebel, Peter; Tammen, Harald; Larsen, Leif Kongskov; Jelsing, Jacob; Vrang, Niels; Klein, Thomas.

Afiliação

Hansen HH; Gubra, Hørsholm Kongevej 11B, 2970, Hørsholm, Denmark. hbh@gubra.dk.
Grønlund RV; Gubra, Hørsholm Kongevej 11B, 2970, Hørsholm, Denmark.
Baader-Pagler T; Department of Cardiometabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co., Biberach, Germany.
Haebel P; Department of Cardiometabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co., Biberach, Germany.
Tammen H; PXBioVisioN, Hannover, Germany.
Larsen LK; Gubra, Hørsholm Kongevej 11B, 2970, Hørsholm, Denmark.
Jelsing J; Gubra, Hørsholm Kongevej 11B, 2970, Hørsholm, Denmark.
Vrang N; Gubra, Hørsholm Kongevej 11B, 2970, Hørsholm, Denmark.
Klein T; Department of Cardiometabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co., Biberach, Germany.

Sci Rep ; 11(1): 8060, 2021 04 13.

Article em En | MEDLINE | ID: mdl-33850212

Assuntos

Inibidores da Dipeptidil Peptidase IV; Linagliptina/farmacologia; Receptores de Neuropeptídeo Y; Animais; Masculino; Camundongos; Camundongos Obesos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Neuropeptídeo Y / Inibidores da Dipeptidil Peptidase IV / Linagliptina Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google